Current treatment status-Undergoing active treatment-Progressive despite treatment - Page 29 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment-Progressive despite treatment Posts on Medivizor

Risks versus benefit of the ‘HIPEC’ treatment for peritoneal metastases due to colorectal cancer

Risks versus benefit of the ‘HIPEC’ treatment for peritoneal metastases due to colorectal cancer

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

Colorectal cancer (CRC) often presents with peritoneal metastases, which have a poor outcome. This means that cancer cells have spread from the colon, appendix, or rectum to the peritoneum (a sheath that covers the abdominal organs). This article argues the pros and cons of a combined treatment for patients with peritoneal metastases from CRC. This...

Read More

The use of systemic chemotherapy for patients with poorly differentiated and signet cell adenocarcinoma of the appendix

The use of systemic chemotherapy for patients with poorly differentiated and signet cell adenocarcinoma of the appendix

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study evaluated the effects of systemic chemotherapy and cytoreductive surgery (CRS) on survival in patients with aggressive types of cancer of the appendix (poorly differentiated and signet ring cell adenocarcinoma). The main findings were that systemic chemotherapy appears to be a viable treatment option for these types of...

Read More

New drugs for advanced prostate cancer

New drugs for advanced prostate cancer

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

The aim of this article was to describe some of the most interesting developments concerning new therapies for advanced prostate cancer. During the last years new experimental therapeutic agents for the treatment of advanced prostate cancer have been developed. These are based on the recent discoveries on prostate cell function, resistance to...

Read More